Plex Research is partnering with Ginkgo Bioworks to use AI to deepen understanding of the mechanisms of action of existing ...
Zacks Investment Research on MSN1d
Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 WeeksGinkgo Bioworks Holdings, Inc. (DNA) has been on a downward spiral lately with significant selling pressure. After declining ...
We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...
Ginkgo Bioworks (DNA) is down -4.8%, or -27c to $5.39.Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall ...
Ginkgo Bioworks Holdings, Inc.’s DNA share price has surged by 11.48%, which has investors questioning if this is right time ...
Ginkgo Bioworks Holdings, Inc. (DNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...
Charles Schwab Investment Management Inc. increased its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) ...
Explore Ginkgo Bioworks Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DNA. Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And ...
Latest data shows the largest indicative borrow rate increases among liquid option names include: Ginkgo Bioworks (DNA) 7.32% +1.48, Kingsoft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback